Home
Applications
Indications
Business
EpiSwitch
®
Products
EpiSwitch
®
Checkpoint Inhibitor Response Test
EpiSwitch
®
COVID-19 Severity Test
EpiSwitch
®
Explorer Array Kit
EPISWITCH
®
ANALYTICAL PORTAL
EpiSwitch
®
Service
Investors
Investors Overview
Results and Presentations
Share Price Information
Regulatory News
Board & Governance
Key Corporate Documents
AIM Rule 26
Email Alerts
Investor Contacts
News
About Us
History
Board of Directors
Management Team
Scientific Advisory Panel
Values
Careers
Contact Us
Drug Discovery Today covers OBD Presentation of
EpiSwitch™
technology application at the Lancet Neurology Conference, London.
October 31, 2016
|
In
Publications
|
By
oxfordbiodynamics
Check out Drug Discovery Today article
Prev
Next
Privacy Preference Center
Privacy Preferences
